Your therapy is a force for good.
Our expertise brings it into the world.
Your leading global combination product CDMO
Kindeva is a global force in combination drug delivery, offering innovative, comprehensive contract development and manufacturing solutions for partners around the world. From ideation through commercialization, our in-house industry expertise and cutting-edge platform technologies enable flexibility and capabilities you won’t find anywhere else.
The therapies you create are a force for good. Kindeva is here to help you bring them into the world.
Are you ready to combine forces?
Pulmonary & Nasal Delivery
As the pioneers of the first pMDI, Kindeva develops and manufactures a full spectrum of pulmonary & nasal drug delivery products from formulation through commercial scale cGMP manufacturing.
As innovators of the autoinjector, Kindeva’s injectable and microneedle technologies provide customized drug-delivery options for commercial and government partners.
A Proven Partner
~ 1300 Patents
75 Inventions In Use
100 + Years of Experience
~ 1 M ft2 cGMP Footprint
2000 + Employees
Join Our Mission
We minimize risks and accelerate timelines by expertly handling everything in-house, all with one ultimate goal: to constantly redefine highest quality with each product we bring to the world. Manufacture more tomorrows for patients alongside us through our new molecule and biologic drug development and leading sustainability and global health security initiatives.
Move your biologic drug development along the investigational pathway with speed and quality backed by Kindeva’s century of expertise.
Keep Up With Kindeva
U.K. Government Grant Unlocks £33M Investment With Kindeva Drug Delivery for Greener Inhaler Future
August 3, 2023